Navigation Links
BMP Sunstone Reports Third Quarter 2009 Financial Results
Date:11/9/2009

5 109 345 885 Non GAAP Gross Profit $15,791 $13,936 $51,073 $38,995 Three Months Ended Nine Months Ended September 30, September 30, 2009 2008 2009 2008 GAAP Operating Income $1,040 $1,765 $4,351 $1,973 Stock Based Compensation 600 636 1,784 1,816 Amortization Related to Acquisitions 887 1,102 2,658 3,279 Non GAAP Operating Income $2,527 $3,503 $8,793 $7,068 Three Months Ended Nine Months Ended September 30, September 30, 2009 2008 2009 2008 GAAP Net Loss $(208) $(816) $(3,913) $(4,882) GAAP EPS $(0.01) $(0.02) $(0.10) $(0.13) Stock Based Compensation 600 636 1,784 1,816 Debt Discount and Premium Amortization and Issuance Cost 58 977 695 2,931 Amortization Related to Acquisitions 887 1,102 2,658 3,279 Loss on Early Extinguishment of Debt -- -- 4,573 -- Gain (Loss) on Derivatives -- -- (1,204) -- Non GAAP Net Income $1,337 $1,899 $4,593 $3,144 Non GAAP EPS $0.03 $0.05 $0.11 $0.08 BMP Sunstone Corporation and Subsidiaries Adjusted EBITDA Reconciliation ($ amounts in thousands) For the Three For the Nine Months Ended Months Ended Se
'/>"/>
SOURCE BMP Sunstone Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. BMP Sunstone Receives SFDA Acceptance for Enablex(R) Clinical Trial
2. BMP Sunstone Receives Import Drug License (IDL) from SFDA
3. BMP Sunstone Corporation Appoints Zhiqiang Han to President and Chief Operating Officer
4. BMP Sunstone Reports Second Quarter 2008 Financial Results
5. BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC
6. BMP Sunstone Announces Participation in September Investor Conference
7. BMP Sunstone Announces Participation in November Investor Conferences
8. BMP Sunstone Reports Third Quarter 2008 Financial Results
9. BMP Sunstone to Host Follow-Up 3Q08 Conference Call Due to Technical Difficulties Encountered on Tuesdays Call
10. BMP Sunstone Acquires Runchang Capsule and Related LFHC Technology
11. BMP Sunstone to Present at the 20th Annual Piper Jaffray Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... ... July 28, 2015 , ... ... EUR 1.022 billion in 2013; while production volume reached close to 1.84 million ... country with a share of 75.5% of the region’s total aluminium hydroxide production; ...
(Date:7/28/2015)... YORK , July 28, 2015 Tauriga ... a diversified life sciences company, today announced that its ... shares of common stock of the Company from 1,000,000,000 ... on July 27, 2015 at the Law Offices of ...  At the Special Meeting, there were 480,655,929 shares of ...
(Date:7/28/2015)... July 28, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... it has granted to German life sciences entrepreneurs ... and commercialization of biotechnology (collectively, the "Optionee"), an ... allogenic tumor vaccine technology (the "Technology"), including AEZS-120, ... which is ready to enter a Phase 1 ...
(Date:7/27/2015)... and FRANKLIN, Tenn. ... a privately-owned  premier provider of health care services ... in the U.S., today announced that its parent ... signed a definitive agreement with Medical Properties Trust, ... acquisition of Capella for $900 million in cash.  The transaction ...
Breaking Biology Technology:EU27 Aluminium Hydroxide Market Analysed and Forecast by BAC Reports in New Research Study Available at MarketPublishers.com 2EU27 Aluminium Hydroxide Market Analysed and Forecast by BAC Reports in New Research Study Available at MarketPublishers.com 3Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 2Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 3Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology 2Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology 3Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 2Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 3Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 4Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 5
... QUARTER 2007 FINANCIAL RESULTS, VANCOUVER, Oct. 25 /PRNewswire-FirstCall/ - ... specialty pharmaceutical and,medical device company, will host a conference call ... 2007. Thursday, November 1, 2007 ... AM Pacific, 9:00 AM Mountain, 10:00 AM Central), ...
... AACR-NCI-EORTC International Conference, SAN DIEGO, ... ANX ), a biopharmaceutical research ... product candidates for the treatment,of cancer ... presented preclinical,results demonstrating that ANX-514, the ...
... uses novel approach to "de-cloak" cancers -, ... (TSX:,ARI), a biotechnology company discovering and developing the ... findings have been,presented from its Trop-2 and CD59 ... and CD59 abstracts at the AACR press,conference today ...
Cached Biology Technology:Notice of Conference Call and Webcast 2ANX-514 Reduces Hypersensitivity Reactions Without Impacting Pharmacokinetics or Antitumor Activity in Preclinical Tests 2ANX-514 Reduces Hypersensitivity Reactions Without Impacting Pharmacokinetics or Antitumor Activity in Preclinical Tests 3ANX-514 Reduces Hypersensitivity Reactions Without Impacting Pharmacokinetics or Antitumor Activity in Preclinical Tests 4ANX-514 Reduces Hypersensitivity Reactions Without Impacting Pharmacokinetics or Antitumor Activity in Preclinical Tests 5Arius announces new findings in Trop-2 and CD59 CANCER antibody programs 2Arius announces new findings in Trop-2 and CD59 CANCER antibody programs 3
(Date:7/23/2015)... July 23, 2015 Research and Markets ... the "Global Outlook of the Biometrics Industry ... The global biometrics market is likely ... commercial applications owing to the uptake of multiple ... transformation that enhances the growth of biometrics in ...
(Date:7/21/2015)... 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ... focused on the growing mobile commerce market and ... it has filed provisional patent 62/192218 for ... This invention highlights next generation payment technology ... but also the user using unique personal identifiers ...
(Date:7/20/2015)... 20, 2015  Acuity Market Intelligence,s latest research ... of Commerce and Privacy" forecasts that between 2014 ... will be downloaded to smart mobile devices by ... market is projected to generate more than $67.9 ... seven-year forecast period.    "Biometrics is ...
Breaking Biology News(10 mins):Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2
... 2010) Today, the Association for Molecular Pathology (AMP) ... Genetics, Health and Society (SACHGS) meeting focused on whole ... and its incorporation into clinical practice, AMP raised ethical ... "In the next five years, the application of ...
... 2010) -- Atmospheric research often focuses on clouds, impact on weather ... with a base some 6,000 feet above earth. University of ... other end of the air column closer to homethe bottom of ... boundary layer. A report on his team,s work appears in a ...
... in the atmosphere rise, policy makers and scientists are ... with the greenhouse gas. One method ... otherwise known as carbon sequestration. CCS, a newly developing ... from the Earth,s atmosphere. Donald J. ...
Cached Biology News:AMP commends SACGHS whole genome sequencing focus, raises ethical questions and forms working group 2AMP commends SACGHS whole genome sequencing focus, raises ethical questions and forms working group 3
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
quantitation of phosphatase activity, evaluation of hits and leads from HTS...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Biology Products: